Attorney General Josh Stein Calls for Passing Anti-Illegal Xylazine Act

For immediate release:
Thursday, May 18, 2023

Contact: Nazneen Ahmed

(Lory) Attorney General Josh Stein today urged Congressional leadership to pass the Anti-Illegal Xylazine Act (HR1839/S.993) to Combat Widespread Illegal Use and Trafficking of Xylazine and Prevent Xylazine-Related Deaths bottom. Xylazine is a powerful veterinary drug that is widely mixed with opioids such as fentanyl and is readily available online. Over the past few months, several federal agencies, including the US Drug Enforcement Administration (DEA), have issued public warnings about the dangers of xylazine. Just recently, the White House declared fentanyl-laced or fentanyl-associated xylazine (FAAX) to be a “new threat” to the nation.

“We need to give law enforcement the tools they need to track down drug traffickers and keep these illegal drugs from flooding our streets,” said Attorney General Josh Stein. “This bill will help save lives in North Carolina and I urge Congress to pass it.”

Xylazine is only approved by the US Food and Drug Administration (FDA) as a veterinary drug used for sedation and pain relief in large animals. Xylazine is known to depress respiration and heart rate, lower blood pressure, and can lead to unconsciousness, necrosis, and even death in humans. Since xylazine is not an opioid, existing antagonists such as naloxone do not have the effect of reversing the effects of the drug even when used in combination with opioids.

According to the DEA, there will be a dramatic increase in xylazine-related overdose deaths across the United States from 2020 to 2021, with a 1,127% increase in the southern United States. Additionally, about 23 percent of fentanyl powders and about 7 percent of fentanyl tablets seized by the DEA in 2022 contained xylazine. To prevent the spread of these pills and drugs in our communities and to keep people safe, Attorney General Stein is calling on Congress to pass anti-illegal xylazine legislation that:

  • Classify the illicit use of xylazine as a Schedule III drug under the Federal Controlled Substances Act.
  • I authorize the DEA to track the manufacture and sale of xylazine and ensure that it is not diverted.
  • Acting through the DEA and working with the FDA Commissioner to request the U.S. Attorney General to submit a report to Congress detailing the prevalence of xylazine, the risks, and recommendations on how to control the illegal use of xylazine do.
  • All salts, isomers and other forms of xylazine should also be covered when restricting illegal drug use.

In North Carolina, Attorney General Stein is also pushing a statewide strategy to address the fentanyl crisis. He is asking Congress for funding to create a fentanyl control unit within the Justice Department to help local district attorneys deal with large-scale fentanyl trafficking, wiretapping and overdose cases. He also advocates for laws such as the Stop Counterfeit Pills Act, which updates North Carolina state laws to address pill press and counterfeit pills containing fentanyl, methamphetamine, and other dangerous drugs, and the New Opioid Control Act, which updates state laws to protect the North. We are also working on supporting it. A Carolinian taking nitadine, an opioid that is 40 times more potent than fentanyl. The State Crime Lab, part of the North Carolina Department of Justice, also has the State Crime Lab’s Division of Drug Chemistry and Toxicology to help scientists quickly and efficiently examine evidence critical to law enforcement investigations. was refurbished.

Attorney General Stein has served in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, and Kentucky. , Louisiana, Maryland, Michigan, Minnesota, Missouri, Nevada, New Hampshire, New Mexico, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin.

A copy of the letter is available here.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *